Literature DB >> 17435662

Plasma testosterone, dehydroepiandrosterone sulfate, and cortisol in female patients with Huntington's disease.

Manolis Markianos1, Marios Panas, Nikos Kalfakis, Dimitrios Vassilopoulos.   

Abstract

OBJECTIVE: The neuronal loss in several brain regions that characterize the progression of Huntington's disease (HD), is expected to influence the activities of hypothalamus-adrenal and hypothalamus-gonadal axes, and the changes may relate to common features of the disease, like depression and dementia. While in male HD patients low plasma testosterone levels have been reported, information on female patients is lacking.
METHODS: We assessed the plasma levels of the androgens total testosterone (TT) and dehydroepiandrosterone sulfate (DHEAS), as well as of cortisol in 41 female patients with HD, confirmed by determination of the CAG repeat number in the IT-15 gene, and searched for associations to the disease symptomatology. We also included a group of 18 females with expanded CAG repeat number in the HD gene (subjects at risk), and a group of 66 age-matched healthy females. Hormone levels of the pre- and post-menopausal subgroups were also compared separately.
RESULTS: Significant negative correlations to age were found for TT and DHEAS in both control (age range 20-71 years) and patient (age range 26 to 78 years) groups, and the calculated decline per year was around 1% for TT and 1.5% for DHEAS. There were no significant differences in hormone levels among patients, subjects at risk and controls, either in premenopausal or in postmenopausal state. The subgroup of patients with depression in their symptomatology had significantly lower TT and DHEAS levels compared to patients without depression, or to controls.
CONCLUSIONS: While TT and DHEAS seem to decline with age in female patients with HD to the same extend as for healthy females, the presence of depression, but not dementia, in their symptomatology, is connected to lower ovary-adrenal androgen levels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17435662

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  9 in total

Review 1.  Association between sex and Huntington's disease: an updated review on symptomatology and prognosis of neurodegenerative disorders.

Authors:  Nimra Hasnain; Taha Bin Arif; Roha Shafaut; Faiza Zakaria; Syeda Zainab Fatima; Ibtehaj Ul Haque
Journal:  Wien Med Wochenschr       Date:  2022-06-20

2.  Towards humane end points: behavioural changes precede clinical signs of disease in a Huntington's disease model.

Authors:  Kate Littin; Abraham Acevedo; William Browne; Joanne Edgar; Mike Mendl; Diane Owen; Chris Sherwin; Hanno Würbel; Christine Nicol
Journal:  Proc Biol Sci       Date:  2008-08-22       Impact factor: 5.349

3.  The relationship between cortisol and verbal memory in the early stages of Huntington's disease.

Authors:  Christopher A Shirbin; Phyllis Chua; Andrew Churchyard; Anthony J Hannan; Georgia Lowndes; Julie C Stout
Journal:  J Neurol       Date:  2012-11-20       Impact factor: 4.849

4.  Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington's disease.

Authors:  X Du; L Leang; T Mustafa; T Renoir; T Y Pang; A J Hannan
Journal:  Transl Psychiatry       Date:  2012-07-03       Impact factor: 6.222

Review 5.  Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?

Authors:  Xin Du; Terence Y Pang
Journal:  Front Psychiatry       Date:  2015-03-09       Impact factor: 4.157

6.  Association Between MKP-1, BDNF, and Gonadal Hormones with Depression on Perimenopausal Women.

Authors:  Ling-yun Hui; Ya-wen Wang; Fu-ling Zhou; Xian-cang Ma; Run-zhi Yan; Lin Zhang; Quan-li Wang; Xuewen Yu
Journal:  J Womens Health (Larchmt)       Date:  2015-07-15       Impact factor: 2.681

7.  Gender Differences in Non-sex Linked Disorders: Insights From Huntington's Disease.

Authors:  Daniel Zielonka; Barbara Stawinska-Witoszynska
Journal:  Front Neurol       Date:  2020-07-07       Impact factor: 4.003

8.  The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease.

Authors:  Rachel Y Cheong; Sanaz Gabery; Åsa Petersén
Journal:  J Huntingtons Dis       Date:  2019

Review 9.  A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.

Authors:  Edina Silajdžić; Maria Björkqvist
Journal:  J Huntingtons Dis       Date:  2018
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.